Literature DB >> 12480683

Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors.

O Kaipiainen-Seppänen1, M Leino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12480683      PMCID： PMC1754304          DOI： 10.1136/ard.62.1.88

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

2.  Pustular skin lesions in patients treated with infliximab: report of two cases.

Authors:  M J F Starmans-Kool; H R M Peeters; H H M L Houben
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

Review 3.  [TNFalpha inhibitors in the treatment of uveitis].

Authors:  K Greiner; J Plskova
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

4.  Pediatric uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2011-10

5.  Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

Authors:  M Rudwaleit; E Rødevand; P Holck; J Vanhoof; M Kron; S Kary; H Kupper
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.